臨床試驗市場規模、佔有率、成長分析，按階段、按服務類型、按治療領域、按應用、按地區 - 行業預測，2024-2031 年

2022年全球臨床試驗市場規模將為482億美元，預測期內（2024-2031年）複合年成長率為8.7%，從2023年的523.9億美元增至2031年的1021億美元。美國2000萬美元。

由於醫療保健的進步、對新型療法的需求不斷增加以及監管機構的支持，全球臨床試驗市場正在經歷強勁成長。市場涵蓋臨床前、I期、II期、III期、IV期等臨床試驗各階段，涵蓋腫瘤學、心臟科、神經科等多個治療領域。包括人工智慧和資料分析整合在內的技術創新正在增強試驗設計、患者招募和資料管理。此外，慢性病盛行率的上升和個人化醫療的推動進一步加速了市場擴張。市場也見證了向分散式臨床試驗的轉變，這提供了更大的靈活性和效率。然而，該市場面臨高成本、監管要求複雜、吸引患者困難等挑戰。儘管存在這些挑戰，但由於持續的技術創新和對改善患者治療效果日益濃厚的興趣，市場有望實現顯著成長。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 市場生態系統
• 重點投資分析
• 關鍵成功因素
• 競爭程度
• 價值鏈分析
• 價格分析
• 技術分析
• 監管分析

臨床試驗市場：按階段

• 市場概況
• III期臨床試驗
• II期臨床試驗
• IV期臨床試驗
• I期臨床試驗

臨床試驗市場：按服務類型

• 市場概況
• 化驗服務
• 生物分析測試服務
  • 基於細胞的檢測
  • 病毒測試
  • 血清學、免疫抗原性、中和抗體
  • PK/PD測試
  • 方法開發、最佳化和檢驗
  • 生物標記測試
  • 其他生物分析測試服務
• 去中心化臨床試驗服務
• 病患招募服務
• 場地識別服務
• 分析測試服務
• 供應及物流服務
• 通訊協定設計服務
• 資料管理服務
• 醫療設備檢測服務
• 其他服務

臨床試驗市場：按治療領域

• 市場概況
• 腫瘤學
• 感染疾病
• 神經病學
• 代謝紊亂
• 免疫學
• 心臟病學
• 遺傳疾病
• 婦女健康
• 其他治療領域

臨床試驗市場：依應用分類

• 市場概況
• 小分子
• 單株抗體
• 疫苗
• 細胞/基因治療
• 其他用途

臨床試驗市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Thermo Fisher Scientific, Inc.（US）
• IQVIA, Inc.（US）
• ICON plc（Ireland）
• Laboratory Corporation of America Holdings（US）
• Syneos Health（US）
• WuXi AppTec（China）
• Charles River Laboratories（US）
• Parexel International Corporation（US）
• Fortrea, Inc.（US）
• Medpace（US）
• SGS（Switzerland）
• Frontage Labs（US）
• ACM Global Laboratories（US）
• Advanced Clinical（US）
• PSI（Switzerland）
• BioAgile（India）
• Clinical Trial Service（Unknown）
• Worldwide Clinical Trials（US）
• Pepgra（India）
• CTI Clinical Trial and Consulting Services（US）

Global Clinical Trials Market size was valued at USD 48.20 billion in 2022 and is poised to grow from USD 52.39 billion in 2023 to USD 102.12 billion by 2031, growing at a CAGR of 8.7% in the forecast period (2024-2031).

Global clinical trials market is experiencing robust growth, driven by advancements in healthcare, increasing demand for novel therapeutics, and regulatory support. The market encompasses various phases of clinical trials, including preclinical, phase I, II, III, and IV, catering to diverse therapeutic areas such as oncology, cardiology, and neurology. Technological innovations, including the integration of artificial intelligence and data analytics, are enhancing trial design, patient recruitment, and data management. Additionally, the rising prevalence of chronic diseases and the push for personalized medicine are further accelerating market expansion. The market is also witnessing a shift towards decentralized clinical trials, which offer greater flexibility and efficiency. However, the market is challenged by high costs, complex regulatory requirements, and patient recruitment difficulties. Despite these challenges, the market is poised for significant growth, driven by continued innovation and the increasing focus on improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Market Segmental Analysis

Global Clinical Trials Market is segmented on the basis of phase, service type, therapeutic area, application, and region. By phase, market is segmented into Phase III Clinical Trials, Phase II Clinical Trials, Phase IV Clinical Trials, and Phase I Clinical Trials. By service type, market is segmented into Laboratory Services, Bioanalytical Testing Services, Decentralized Clinical Trial Services, Patient Recruitment Services, Site Identification Services, Analytical Testing Services, Supply & Logistics Services, Protocol Designing Services, Data Management Services, Medical Device Testing Services, and Other Services. By therapeutic area, market is segmented into Oncology, Infectious Diseases, Neurology, Metabolic Disorders, Immunology, Cardiology, Genetic Diseases, Women's Health, and Other Therapeutic Areas. By application, market is segmented into Small Molecules, Monoclonal Antibodies, Vaccines, Cell & Gene Therapy, and Other Applications. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Clinical Trials Market

Technological advancements are a major driver of the clinical trials market. Innovations such as electronic data capture (EDC) systems, wearable devices, and mobile health applications are transforming how clinical trials are conducted. These technologies enhance data accuracy, streamline patient monitoring, and improve the efficiency of trial operations. For instance, EDC systems facilitate real-time data collection and analysis, reducing the risk of errors and expediting regulatory submissions. Wearable devices enable continuous health monitoring, providing valuable insights into patient responses and treatment efficacy. Mobile health applications improve patient engagement and adherence, allowing for remote participation and data collection. As technology continues to evolve, it is expected to drive further growth in the clinical trials market by making trials more efficient, cost-effective, and patient-centric.

Restraints in the Clinical Trials Market

High costs represent a significant restraint in the clinical trials market. Conducting clinical trials involves substantial expenses, including those related to trial design, site management, patient recruitment, and regulatory compliance. The costs associated with hiring specialized staff, purchasing equipment, and managing data are substantial, often reaching millions of dollars for a single trial. Additionally, the lengthy and complex process of obtaining regulatory approvals and ensuring compliance with international standards further inflates costs. These financial burdens can be particularly challenging for smaller organizations and biotech firms with limited resources. As a result, the high cost of clinical trials can slow down the development of new therapies and limit the participation of smaller players in the market.

Market Trends of the Clinical Trials Market

Decentralized clinical trials (DCTs) are emerging as a significant trend in the clinical trials market. This approach leverages technology to conduct trials remotely, reducing the need for traditional site-based visits. DCTs utilize digital tools such as mobile apps, wearable devices, and telemedicine to facilitate patient participation and data collection from home or local healthcare providers. This model offers several advantages, including increased patient accessibility, improved retention rates, and reduced operational costs. By minimizing the logistical challenges associated with traditional trials, DCTs enable faster recruitment and more diverse patient populations. The trend towards decentralized trials is expected to continue growing as stakeholders seek more flexible, patient-centric, and efficient methods for conducting clinical research, ultimately enhancing trial outcomes and accelerating the development of new treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis

Clinical Trials Market by Phase

• Market Overview
• Phase III Clinical Trials
• Phase II Clinical Trials
• Phase IV Clinical Trials
• Phase I Clinical Trials

Clinical Trials Market by Service Type

• Market Overview
• Laboratory Services
• Bioanalytical Testing Services
  • Cell-Based Assays
  • Virology Testing
  • Serology, Immunogenicity, And Neutralizing Antibodies
  • PK/PD Testing
  • Method Development, Optimization, And Validation
  • Biomarker Testing
  • Other Bioanalytical Testing Services
• Decentralized Clinical Trial Services
• Patient Recruitment Services
• Site Identification Services
• Analytical Testing Services
• Supply & Logistics Services
• Protocol Designing Services
• Data Management Services
• Medical Device Testing Services
• Other Services

Clinical Trials Market by Therapeutic Area

• Market Overview
• Oncology
• Infectious Diseases
• Neurology
• Metabolic Disorders
• Immunology
• Cardiology
• Genetic Diseases
• Women's Health
• Other Therapeutic Areas

Clinical Trials Market by Application

• Market Overview
• Small Molecules
• Monoclonal Antibodies
• Vaccines
• Cell & Gene Therapy
• Other Applications

Clinical Trials Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortrea, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Labs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Clinical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgile (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Trial Service (Unknown)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pepgra (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments